Accounting for the effects of moderately increased pressure on the energetics of melting and solubility in metered dose inhalers

Erik Mogalian, Kia Sepassi, Paul B Myrdal

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The purpose of this study is to account for thermodynamic variations due to changes in the physical environment of propellant-based systems, particularly metered dose inhalers (MDIs). Twenty organic compounds were measured via differential scanning calorimetry under ambient pressure, 60 psi, and 90 psi. The increase in pressure did not affect the melting point of any of the compounds. A modest increase (∼8%) in enthalpy of fusion was noted. This correlates to a modest increase in entropy of fusion, and thus ideal crystalline solubility, though the magnitude of this change depends primarily on the melting point of the given compound. Because the relationship between melting point and solubility is logarithmic, compounds with higher melting points are affected more by this increased energy of melting. Based on the findings, modest changes can be made to predictive models to estimate solubility in propellant systems to account for changes in the physical environment of MDIs.

Original languageEnglish (US)
Pages (from-to)930-935
Number of pages6
JournalDrug Development and Industrial Pharmacy
Volume34
Issue number9
DOIs
StatePublished - Sep 2008

Fingerprint

Metered Dose Inhalers
Solubility
Freezing
Melting point
Melting
Pressure
Propellants
Fusion reactions
Organic compounds
Differential Scanning Calorimetry
Entropy
Differential scanning calorimetry
Enthalpy
Thermodynamics
Crystalline materials

Keywords

  • 134a
  • Hydrofluoroalkane
  • Metered dose inhaler
  • Pressure
  • Propellant
  • Solubility

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Organic Chemistry

Cite this

Accounting for the effects of moderately increased pressure on the energetics of melting and solubility in metered dose inhalers. / Mogalian, Erik; Sepassi, Kia; Myrdal, Paul B.

In: Drug Development and Industrial Pharmacy, Vol. 34, No. 9, 09.2008, p. 930-935.

Research output: Contribution to journalArticle

@article{a1d35cb6db674f5dbdf8d2d0148df861,
title = "Accounting for the effects of moderately increased pressure on the energetics of melting and solubility in metered dose inhalers",
abstract = "The purpose of this study is to account for thermodynamic variations due to changes in the physical environment of propellant-based systems, particularly metered dose inhalers (MDIs). Twenty organic compounds were measured via differential scanning calorimetry under ambient pressure, 60 psi, and 90 psi. The increase in pressure did not affect the melting point of any of the compounds. A modest increase (∼8{\%}) in enthalpy of fusion was noted. This correlates to a modest increase in entropy of fusion, and thus ideal crystalline solubility, though the magnitude of this change depends primarily on the melting point of the given compound. Because the relationship between melting point and solubility is logarithmic, compounds with higher melting points are affected more by this increased energy of melting. Based on the findings, modest changes can be made to predictive models to estimate solubility in propellant systems to account for changes in the physical environment of MDIs.",
keywords = "134a, Hydrofluoroalkane, Metered dose inhaler, Pressure, Propellant, Solubility",
author = "Erik Mogalian and Kia Sepassi and Myrdal, {Paul B}",
year = "2008",
month = "9",
doi = "10.1080/03639040802154871",
language = "English (US)",
volume = "34",
pages = "930--935",
journal = "Drug Development and Industrial Pharmacy",
issn = "0363-9045",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Accounting for the effects of moderately increased pressure on the energetics of melting and solubility in metered dose inhalers

AU - Mogalian, Erik

AU - Sepassi, Kia

AU - Myrdal, Paul B

PY - 2008/9

Y1 - 2008/9

N2 - The purpose of this study is to account for thermodynamic variations due to changes in the physical environment of propellant-based systems, particularly metered dose inhalers (MDIs). Twenty organic compounds were measured via differential scanning calorimetry under ambient pressure, 60 psi, and 90 psi. The increase in pressure did not affect the melting point of any of the compounds. A modest increase (∼8%) in enthalpy of fusion was noted. This correlates to a modest increase in entropy of fusion, and thus ideal crystalline solubility, though the magnitude of this change depends primarily on the melting point of the given compound. Because the relationship between melting point and solubility is logarithmic, compounds with higher melting points are affected more by this increased energy of melting. Based on the findings, modest changes can be made to predictive models to estimate solubility in propellant systems to account for changes in the physical environment of MDIs.

AB - The purpose of this study is to account for thermodynamic variations due to changes in the physical environment of propellant-based systems, particularly metered dose inhalers (MDIs). Twenty organic compounds were measured via differential scanning calorimetry under ambient pressure, 60 psi, and 90 psi. The increase in pressure did not affect the melting point of any of the compounds. A modest increase (∼8%) in enthalpy of fusion was noted. This correlates to a modest increase in entropy of fusion, and thus ideal crystalline solubility, though the magnitude of this change depends primarily on the melting point of the given compound. Because the relationship between melting point and solubility is logarithmic, compounds with higher melting points are affected more by this increased energy of melting. Based on the findings, modest changes can be made to predictive models to estimate solubility in propellant systems to account for changes in the physical environment of MDIs.

KW - 134a

KW - Hydrofluoroalkane

KW - Metered dose inhaler

KW - Pressure

KW - Propellant

KW - Solubility

UR - http://www.scopus.com/inward/record.url?scp=52449116926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52449116926&partnerID=8YFLogxK

U2 - 10.1080/03639040802154871

DO - 10.1080/03639040802154871

M3 - Article

VL - 34

SP - 930

EP - 935

JO - Drug Development and Industrial Pharmacy

JF - Drug Development and Industrial Pharmacy

SN - 0363-9045

IS - 9

ER -